$7.43
-0.30-3.88%
At close: Nov 11, 4:00 PM EST
$7.50
-0.23-2.98%
Pre-Market: 5:25 AM EST
Kura Oncology Inc
KURANASDAQ
Kura Oncology fell 30.4% from $10.68 to $7.43, behind the S&P 500's +12.7%. Its worst day was Nov 4 (−23.0%), and its low came Nov 5 at $6.80.
Nov 13, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Kura Oncology shares rose 14.5%, while the S&P 500 rose 0.6%.
+14.5% · S&P 500 +0.6%
EPS of $-0.92 missed the $-0.58 estimate on $17.3M revenue (est. $33.2M).
−0.5% · S&P 500 −0.6%
Story events cover the past 12 months · Times ET
EPS of $-0.83 missed the $-0.80 estimate on $18.3M revenue (est. $23.7M).
−2.1% · S&P 500 +0.6%
Kura Oncology shares fell 11.4%, while the S&P 500 rose 0.3%.
−11.4% · S&P 500 +0.3%
EPS of $-0.77 beat the $-0.88 estimate on $20.9M revenue (est. $19.5M).
+1.5% · S&P 500 +0.7%
Kura Oncology closed at its highest level of the year, 27.2% above where the year started.
+9.6% · S&P 500 +0.3%
EPS of $-0.78 beat the $-0.81 estimate on $22.8M revenue (est. $23.6M).
+2.1% · S&P 500 +1.3%
Where it ended: a close of $7.43 on Nov 12, 2026. Up next: Q4 2026 earnings on Mar 4, 2027 (EPS est. $-0.76, revenue est. $30.9M).
Nothing in the past 12 months.
All KURA dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for KURA and SPY from Benzinga historical bars. Not investment advice.
